Brief: Reneo Pharmaceuticals Announces Stockholder Approval Of Merger With Onkure
03/10/2024 01:22
Oct 2 (Reuters) - Reneo Pharmaceuticals Inc RPHM.O :
* RENEO PHARMACEUTICALS ANNOUNCES STOCKHOLDER APPROVAL OF
MERGER
WITH ONKURE
* RENEO PHARMACEUTICALS INC - ANNOUNCES 1-FOR-10 REVERSE
SPLIT OF
COMMON STOCK
* RENEO PHARMACEUTICALS INC - COMBINED COMPANY TO TRADE ON
NASDAQ
UNDER TICKER 'OKUR'
Source text for Eikon: ID:nGNXb4qGvJ
Further company coverage: RPHM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker